Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-30 12:10 pm Purchase | 2025-05-27 | 13G | AEON Biopharma, Inc. AEON | Chernett Jorey | 1,128,500 9.900% | 1,128,500 (New Position) | Filing History |
| 2025-05-15 7:21 pm Purchase | 2025-03-31 | 13G | AEON Biopharma, Inc. AEON | L1 Capital Global Opportunities Master Fund, Ltd. | 465,029 4.110% | 340,585 (+273.68%) | Filing History |
| 2025-05-15 6:35 pm Sale | 2025-03-31 | 13G | AEON Biopharma, Inc. AEON | S.H.N. Financial Investments Ltd. | 0 0.000% | -75,000 (Position Closed) | Filing History |
| 2025-05-15 07:07 am Sale | 2025-03-31 | 13G | AEON Biopharma, Inc. AEON | Polar Asset Management Partners Inc. | 0 0.000% | -38,371 (Position Closed) | Filing History |
| 2025-03-10 08:45 am Purchase | 2025-02-28 | 13G | AEON Biopharma, Inc. AEON | Alta Partners LLC | 629,614 6.230% | 629,614 (New Position) | Filing History |
| 2025-03-07 4:01 pm Purchase | 2024-07-25 | 13D | AEON Biopharma, Inc. AEON | PALMISANO ROBERT J | 2,265,000 5.700% | 2,233,542 (+7100.00%) | Filing History |
| 2025-03-03 1:51 pm Purchase | 2025-02-26 | 13G | AEON Biopharma, Inc. AEON | Dauntless Investment Group, LLC | 108,224 9.700% | 108,224 (New Position) | Filing History |
| 2025-02-14 5:09 pm Sale | 2024-12-31 | 13G | AEON Biopharma, Inc. AEON | Blue Owl Capital Holdings LP | 42,352 3.810% | -4,053 (-8.73%) | Filing History |
| 2025-02-14 4:44 pm Sale | 2024-12-31 | 13G | AEON Biopharma, Inc. AEON | Polar Asset Management Partners Inc. | 38,371 6.900% | -12,671 (-24.82%) | Filing History |
| 2025-01-22 4:02 pm Purchase | 2024-07-25 | 13D | AEON Biopharma, Inc. AEON | PALMISANO ROBERT J | 31,458 5.700% | 31,458 (New Position) | Filing History |
| 2025-01-13 4:14 pm Purchase | 2025-01-06 | 13G | AEON Biopharma, Inc. AEON | S.H.N. Financial Investments Ltd. | 75,000 6.000% | 75,000 (New Position) | Filing History |
| 2025-01-13 4:08 pm Purchase | 2025-01-06 | 13G | AEON Biopharma, Inc. AEON | L1 Capital Global Opportunities Master Fund, Ltd. | 124,444 9.990% | 124,444 (New Position) | Filing History |
| 2025-01-08 4:15 pm Purchase | 2025-01-06 | 13G | AEON Biopharma, Inc. AEON | BIGGER CAPITAL FUND L P | 68,056 6.100% | 68,056 (New Position) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | AEON Biopharma, Inc. AEON | Blue Owl Capital Holdings LP | 46,406 8.450% | 46,406 (New Position) | Filing History |
| 2024-02-14 1:46 pm Purchase | 2023-12-31 | 13G | AEON Biopharma, Inc. AEON | Polar Asset Management Partners Inc. | 51,042 9.900% | 51,042 (New Position) | Filing History |
| 2024-02-14 09:00 am Unchanged | 2023-12-31 | 13G | AEON Biopharma, Inc. AEON | Empyrean Capital Partners LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-08-22 4:37 pm Sale | 2023-08-11 | 13D | AEON Biopharma, Inc. AEON | Strathspey Crown Holdings Group LLC | 28,219 5.470% | -102,619 (-78.43%) | Filing History |
| 2023-07-31 4:45 pm Purchase | 2023-07-21 | 13D | AEON Biopharma, Inc. AEON | Strathspey Crown Holdings Group LLC | 130,838 25.400% | 130,838 (New Position) | Filing History |
| 2023-07-31 4:15 pm Purchase | 2023-07-27 | 13G | AEON Biopharma, Inc. AEON | Atalaya Capital Management LP | 51,042 9.890% | 51,042 (New Position) | Filing History |
| 2023-07-28 07:55 am Purchase | 2023-07-28 | 13D | AEON Biopharma, Inc. AEON | Daewoong Co. Ltd | 91,356 23.980% | 91,356 (New Position) | Filing History |